(NASDAQ: PGEN) Precigen's forecast annual revenue growth rate of 168.85% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.43%.
Precigen's revenue in 2024 is $4,389,000.On average, 3 Wall Street analysts forecast PGEN's revenue for 2024 to be $822,996,468, with the lowest PGEN revenue forecast at $449,918,217, and the highest PGEN revenue forecast at $1,213,262,606. On average, 2 Wall Street analysts forecast PGEN's revenue for 2025 to be $5,214,501,577, with the lowest PGEN revenue forecast at $824,007,520, and the highest PGEN revenue forecast at $9,604,995,634.
In 2026, PGEN is forecast to generate $26,681,666,819 in revenue, with the lowest revenue forecast at $26,681,666,819 and the highest revenue forecast at $26,681,666,819.